Mutations within the cyclin A CLS reduce Cdk binding. (A) CHO-K1 cells were transfected with DNA constructs encoding EGFP-fused cyclin A Fl wt, cyclin A Fl DWVE-A or cyclin A aa 1–200 (control without a CLS). The resulting EGFP-proteins were immunoprecipitated with anti EGFP antibodies, and the efficiency of immunoprecipitation monitored by western blotting using anti-cyclin A antibodies (upper part). The binding to Cdk in the immunoprecipitate was monitored by western blot with PSTAIRE antibodies (middle part), whereas Cdk kinase activity was assayed in the immune-complex using histone H1 as a substrate (lower part, autoradiograph). (B) Ribbon diagram showing the interaction between Cdk2 (brown) and cyclin A (cyan) in the cyclin A-Cdk2 complex (PDB 1JSU). The site of the mutated residues within the cyclin A CLS region (magenta) and the major contact regions of the Cdk PSTAIRE helix and T loop are shown in red. Mutation in the cyclin A CLS, and particularly the substitution of W217 to alanine may affect the conformation of the surrounding α-helices (α3 and α4) that have multiple direct contacts (T258, I281, T282) with this residue and indirectly participate in the interaction with Cdk2 through helix α5. (C) Ribbon diagram showing the interaction between Cdk2 (brown) and cyclin E (green) in the cyclin E-Cdk2 complex (PDB 1W98). The site of the cyclin E CLS region (yellow) containing the SWNQ mutated residues, and the Cdk PSTAIRE helix and T loop are shown in red. This view highlights the proximity of the SWNQ residues to the N-helix, where cyclin E W234 contacts L229, M105 and W102, and the tip of the T loop, but does not contact the PSTAIRE helix of Cdk2.